HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

W L Gross Selected Research

Therapeutics

6/2011[Therapy of vasculitides: according to recommendations of the European League Against Rheumatism (EULAR) and European Vasculitis Study Group (EUVAS)].
10/2010[Classification and therapy of vasculitis according to recommendations of the European League Against Rheumatism (EULAR)].
10/2009[Large-vessel vasculitis. Imaging and interventional therapy].
8/2009[Imaging techniques in the evaluation of primary large vessel vasculitides: part 1: angiography, interventional therapy, and magnetic resonance imaging].
5/2009ANCA-associated vasculitides: pathogenetic aspects and current evidence-based therapy.
3/2009[Autoimmune vasculitides. Standards and guidelines of EULAR and EUVAS].
8/2008The leucotriene receptor antagonist montelukast and the risk of Churg-Strauss syndrome: a case-crossover study.
7/2008[Risk of infection by biologics].
5/2008A phase II study of interferon-alpha for the treatment of refractory Churg-Strauss syndrome.
9/2007Sustained success of therapy with inhaled iloprost for severe pulmonary arterial hypertension associated with systemic sclerosis and pulmonary fibrosis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


W L Gross Research Topics

Disease

40Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
01/2013 - 03/2000
27Vasculitis (Vasculitides)
02/2014 - 01/2000
14Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
05/2014 - 01/2000
12Systemic Vasculitis
02/2010 - 01/2000
12Churg-Strauss Syndrome (Allergic Angiitis)
08/2008 - 03/2000
10Rheumatoid Arthritis
07/2008 - 12/2000
8Inflammation (Inflammations)
11/2012 - 04/2001
7Microscopic Polyangiitis
12/2005 - 03/2000
5Rheumatic Diseases (Rheumatism)
06/2012 - 02/2001
5Infections
07/2008 - 05/2000
5Pulmonary Arterial Hypertension
09/2007 - 12/2004
4Autoimmune Diseases (Autoimmune Disease)
07/2008 - 03/2000
4Necrosis
07/2006 - 05/2000
3Giant Cell Arteritis (Horton Disease)
06/2012 - 04/2005
3Granuloma
11/2011 - 07/2008
3Systemic Scleroderma (Systemic Sclerosis)
09/2007 - 12/2004
3Eosinophilia
09/2007 - 01/2002
3Communicable Diseases (Infectious Diseases)
06/2004 - 01/2000
3Cystic Fibrosis (Mucoviscidosis)
08/2003 - 05/2000
2Glomerulonephritis
11/2012 - 12/2003
2Multiple Sclerosis
09/2009 - 02/2006
2Fever (Fevers)
06/2009 - 08/2004
2Asthma (Bronchial Asthma)
08/2008 - 11/2003
2Bacterial Infections (Bacterial Infection)
07/2008 - 08/2003
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2006 - 06/2004
2Peripheral Nervous System Diseases (PNS Diseases)
12/2005 - 02/2001
2Vascular Diseases (Vascular Disease)
04/2005 - 03/2000
2Connective Tissue Diseases (Connective Tissue Disease)
11/2003 - 08/2001
2Cryoglobulinemia
11/2003 - 05/2000
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
11/2003 - 04/2001
2Gram-Negative Bacterial Infections
08/2003 - 04/2001
1Esophagitis
06/2012
1Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis)
06/2012
1Rheumatoid Vasculitis
02/2010
1Aneurysm (Aneurysms)
10/2009
1Hyperplasia
10/2009
1Pathologic Constriction (Stenosis)
10/2009
1Familial Mediterranean Fever (Periodic Disease)
06/2009
1Blau syndrome
06/2009
1Pyogenic arthritis, pyoderma gangrenosum, and acne
06/2009
1Hereditary Autoinflammatory Diseases
06/2009
1Tertiary Lymphoid Structures
12/2008
1Tuberculosis (Tuberculoses)
07/2008
1Hypereosinophilic Syndrome (Loeffler Endocarditis)
03/2008

Drug/Important Bio-Agent (IBA)

31Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
05/2014 - 01/2000
14Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2009 - 01/2000
11AutoantibodiesIBA
01/2013 - 01/2000
9Myeloblastin (Proteinase 3)IBA
02/2014 - 01/2000
9AntibodiesIBA
11/2005 - 01/2000
8CytokinesIBA
10/2009 - 07/2000
8Methotrexate (Mexate)FDA LinkGeneric
03/2009 - 09/2002
7AntigensIBA
02/2014 - 01/2000
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2008 - 05/2000
6bactericidal permeability increasing proteinIBA
02/2005 - 01/2000
5GlucocorticoidsIBA
06/2012 - 07/2003
5Prednisolone (Predate)FDA LinkGeneric
07/2006 - 12/2003
4Interferon-alpha (Interferon Alfa)IBA
05/2008 - 05/2000
4Bosentan (Tracleer)FDA Link
09/2007 - 12/2004
4Rituximab (Mabthera)FDA Link
08/2006 - 12/2003
4Azathioprine (Imuran)FDA LinkGeneric
10/2004 - 07/2001
4Peroxidase (Myeloperoxidase)IBA
11/2002 - 05/2000
3Peptide Hydrolases (Proteases)FDA Link
05/2008 - 02/2001
3Leflunomide (Arava)FDA LinkGeneric
07/2007 - 03/2004
3Immunoglobulin M (IgM)IBA
06/2004 - 08/2001
3SteroidsIBA
01/2004 - 09/2002
3EnzymesIBA
11/2002 - 01/2000
3ImmunosorbentsIBA
11/2002 - 01/2000
3Immunoglobulin G (IgG)IBA
08/2001 - 05/2000
2HMGB1 Protein (HMG1)IBA
11/2011 - 10/2010
2Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
06/2009 - 08/2004
2Interleukin-10 (Interleukin 10)IBA
06/2008 - 11/2001
2Interleukin-5 (Interleukin 5)IBA
09/2007 - 06/2005
2Iloprost (Ventavis)FDA Link
09/2007 - 05/2005
2Interleukin-4 (Interleukin 4)IBA
06/2005 - 02/2001
2Interleukin-13IBA
06/2005 - 02/2001
2CollagenIBA
04/2005 - 03/2000
2Antinuclear AntibodiesIBA
06/2004 - 03/2000
2Adrenal Cortex Hormones (Corticosteroids)IBA
11/2002 - 04/2002
2Infliximab (Remicade)FDA Link
11/2002 - 09/2002
2Anticardiolipin AntibodiesIBA
08/2001 - 05/2000
2Antigen-Antibody Complex (Immune Complex)IBA
04/2001 - 03/2000
2Complement System Proteins (Complement)IBA
05/2000 - 03/2000
1Toll-Like Receptors (Toll-Like Receptor)IBA
05/2014
1Toll-Like Receptor 9IBA
05/2014
1HLA-DP Antigens (HLA-DP)IBA
02/2014
1Ferritins (Ferritin)IBA
06/2012
1cyclic citrullinated peptideIBA
02/2010
1Mitochondrial DNA (mtDNA)IBA
09/2009
1Immunoglobulin D (IgD)IBA
06/2009
1Pattern Recognition ReceptorsIBA
06/2009
1Immunosuppressive Agents (Immunosuppressants)IBA
03/2009
1montelukast (Singulair)FDA Link
08/2008
1HLA-DPB1 antigen (HLA DPB1)IBA
07/2008
1C-Reactive ProteinIBA
07/2008
1Tumor Necrosis Factor InhibitorsIBA
07/2008
1InterleukinsIBA
05/2008

Therapy/Procedure

23Therapeutics
06/2011 - 01/2000
8Remission Induction
03/2009 - 09/2002
2Contraindications
07/2008 - 09/2007
1Surgical Amputation (Amputations)
05/2008